SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...
At this year’s AACR 2025 (Chicago, IL, USA; 25–30 April), the annual meeting of the American Association for Cancer Research, we picked out our favourite posters from the conference and spoke to their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results